IPEC e-newsletter - Excipients Insight April 2011 - 27-04-11


Inside this issue


Word of the Chair

Welcome everyone.

In this month’s edition of Excipients Insight our committees have put together very good summaries of their activities and the progress made so far on the various subjects which continue to impact the excipient front.

To mention a few, the subject of Quality by Design is here to stay. IPEC Europe continues to follow its evolution as the pharmaceutical market develops into a more congruous industry with a common understanding and language as to how quality products can be better achieved through predefined objectives which highlight product and process understanding and process control according to sound science and quality risk management. A new team comprised of experts in the industry has also been created to address the specific requirements on excipient risk assessment. The update on Excipact provides the most recent work undertaken by the different teams and task forces to precipitate the project. We should in the coming months be offering our members webinar updates on all these developments and providing a good forum for a more open exchange of ideas and views.

I hope you will enjoy and find this edition very useful.  If there are any particular topics you would like us to consider during future publications and/or would like to join any one of the committees, please let us know.

Best wishes,
Beam Suffolk




Copyright © 2005 - 2018 IPEC Europe - International Pharmaceutical Excipients Council